ADH1C and hepatocellular carcinoma: To validate whether ANLN, ENTPD2, TRIP13, PLAC8, and G6PD are highly expressed and ADH1C are lowly expressed in HCC tissues, we experimentally validated the expression in the tissues of 44 HCC patients.